Production (Stage)
ALX Oncology Holdings Inc.
ALXO
$0.4637
-$0.0152-3.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.93M | 7.08M | 6.10M | 6.87M | 6.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.82M | 30.61M | 32.57M | 41.53M | 37.76M |
| Operating Income | -31.82M | -30.61M | -32.57M | -41.53M | -37.76M |
| Income Before Tax | -30.75M | -29.16M | -30.71M | -39.40M | -35.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.75M | -29.16M | -30.71M | -39.40M | -35.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.75M | -29.16M | -30.71M | -39.40M | -35.58M |
| EBIT | -31.82M | -30.61M | -32.57M | -41.53M | -37.76M |
| EBITDA | -31.61M | -30.40M | -32.35M | -40.86M | -37.55M |
| EPS Basic | -0.58 | -0.55 | -0.58 | -0.76 | -0.71 |
| Normalized Basic EPS | -0.36 | -0.35 | -0.36 | -0.48 | -0.44 |
| EPS Diluted | -0.58 | -0.55 | -0.58 | -0.76 | -0.71 |
| Normalized Diluted EPS | -0.36 | -0.35 | -0.36 | -0.48 | -0.44 |
| Average Basic Shares Outstanding | 53.36M | 52.80M | 52.69M | 51.83M | 50.12M |
| Average Diluted Shares Outstanding | 53.36M | 52.80M | 52.69M | 51.83M | 50.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |